HOME >> BIOLOGY >> NEWS
Enzyme increases number, size of heart muscle cells in mice

HOUSON--Mice that were genetically engineered to produce a protein found in embryos and stem cells produce more as well as bigger heart cells, which live longer than those in normal mice, according to scientists at Baylor College of Medicine.

The report, in the Aug. 21 online version of the Proceedings of the National Academy of Sciences and in the Aug. 28 printed edition, advances the understanding of how heart muscle cells proliferate and grow and could prove important in treating the 1.5 million Americans who suffer heart attacks each year and the 4.7 million who have congestive heart failure.

Understanding how this enzyme works gives us new information about normal control of heart muscle growth and could be important in bringing gene-based and cell-based therapies to bear on diseases of the heart, said Dr. Michael Schneider, senior author of the paper and a professor of medicine, cell biology, and molecular physiology and biophysics at Baylor.

Schneider and his co-workers engineered mice genetically to continue producing the enzyme telomerase reverse transcriptase, or TERT, in heart muscle after birth. TERT enables the ends of the chromosomes, called telomeres, to be copied completely during cell division. Telomeres cap the ends of chromosomes, like plastic tips on shoelaces. Ordinarily, after organisms are born, TERT production stops in most types of cells, and telomeres shorten in the process of aging.

The mice produced in Schneiders laboratory make TERT at concentrations usually seen only in embryos. In the first month after birth, heart muscle cells in the mice hearts continued to proliferate, dividing and making more cells at a time when there would usually be no new cells. TERT production continued as the mice aged, but eventually the cells stopped dividing and instead grew bigger. This condition, called hypertrophy, usually weakens heart muscle. However, tests show that the hearts in the mice resembled the enlarged o
'"/>

Contact: Anissa Anderson Orr
anissaa@bcm.tmc.edu
713-798-4713
Baylor College of Medicine
20-Aug-2001


Page: 1 2

Related biology news :

1. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival
2. Enzyme activation appears key in helping internal clock tell night from day
3. Enzyme fully degrades mad cow disease prion
4. Enzyme revealed that is key to funguss ability to breach immune system
5. Enzyme discovery sheds light on causes of rare disease, cancer
6. Enzyme could overcome industrial bleaching waste problems
7. Enzyme controls good cholesterol
8. Enzyme discovery to benefit homeland security, industry
9. Enzyme could aid cancer fight
10. Enzyme once thought harmful to Alzheimers patients now appears key to future treatment
11. Enzyme mimetic reduces tissue damage in colitis animal study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... CITY, Calif. (PRWEB) , ... July 01, 2020 ... ... biotech company, presented its phase 1a findings of Neihulizumab, a biologic for the ... conference in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... and solutions for glioblastoma—the most common and aggressive adult brain cancer—announced today the ... PhD. Senior Fellows are charged with supporting the organization’s initiatives and overall vision. ...
(Date:6/25/2020)... (PRWEB) , ... June 24, 2020 , ... ... cloud-based enterprise software and software-driven clinical data services that accelerate drug development, is ... low-dose selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... ... After research model surgery and catheter implantation, the long journey of catheter ... of a successful study, while protecting and accessing the catheter or device post-surgery is ... from Envigo in a live webinar on Wednesday, August 5, ...
(Date:7/18/2020)... ... 16, 2020 , ... Medial EarlySign , a leader ... of high-burden diseases, and Centric Consulting, a business and technology consulting firm, today ... data in order to identify and prioritize patients for care. , Combining Centric’s ...
(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... testing services and products, announces a significant expansion of laboratory operations through its ... collection for agencies implementing testing programs. , Bode-CARES provides a ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most ... used to suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate ... Dr MA has been using the zebrafish model to investigate the causes of ...
Breaking Biology Technology:
Cached News: